Literature DB >> 32387817

Machine-learning models for depression and anxiety in individuals with immune-mediated inflammatory disease.

Lana G Tennenhouse1, Ruth Ann Marrie2, Charles N Bernstein3, Lisa M Lix4.   

Abstract

OBJECTIVE: Individuals with immune-mediated inflammatory disease (IMID) have a higher prevalence of psychiatric disorders than the general population. We utilized machine-learning to identify patient-reported outcome measures (PROMs) that accurately predict major depressive disorder (MDD) and anxiety disorder in an IMID population.
METHODS: Participants with IMID were enrolled in a cohort study and completed a Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID), and multiple PROMs. PROM items were ranked separately for MDD and anxiety disorder by the standardized mean difference between individuals with and without psychiatric disorders. Items were added sequentially to logistic regression (LR), neural network (NN), and random forest (RF) models. Discriminative performance was assessed with area under the receiver operator curve (AUC) and calibration was assessed with Brier scores. Ten-fold cross-validation was used.
RESULTS: Of 637 participants, 75% were female and average age was 51 years. AUC and Brier scores respectively ranged from 0.87-0.91 and 0.07 (i.e., no variation) for MDD models, and from 0.79-0.83 and 0.09-0.11 for anxiety disorder models. In LR and NN, few PROM items were required to obtain optimal discriminatory performance. RF did not perform as well as LR and NN when few PROM items were included.
CONCLUSIONS: Predictive model performance was respectable and revealed insight into PROM items that are predictive of MDD and anxiety disorder. Models that included only the items 'I felt depressed' and 'I felt like I needed help for my anxiety' performed similarly to models that included all items from multiple PROMs.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Immune-mediated inflammatory disease; Machine-learning; Patient-reported outcome measures (PROMs)

Year:  2020        PMID: 32387817     DOI: 10.1016/j.jpsychores.2020.110126

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  6 in total

1.  Predictive utility of symptom measures in classifying anxiety and depression: A machine-learning approach.

Authors:  Kevin Liu; Brian Droncheff; Stacie L Warren
Journal:  Psychiatry Res       Date:  2022-03-28       Impact factor: 11.225

2.  Chinese College Students Have Higher Anxiety in New Semester of Online Learning During COVID-19: A Machine Learning Approach.

Authors:  Chongying Wang; Hong Zhao; Haoran Zhang
Journal:  Front Psychol       Date:  2020-12-03

Review 3.  A Study of the Recent Trends of Immunology: Key Challenges, Domains, Applications, Datasets, and Future Directions.

Authors:  Sharnil Pandya; Aanchal Thakur; Santosh Saxena; Nandita Jassal; Chirag Patel; Kirit Modi; Pooja Shah; Rahul Joshi; Sudhanshu Gonge; Kalyani Kadam; Prachi Kadam
Journal:  Sensors (Basel)       Date:  2021-11-23       Impact factor: 3.576

4.  Person centred care provision and care planning in chronic kidney disease: which outcomes matter? A systematic review and thematic synthesis of qualitative studies : Care planning in CKD: which outcomes matter?

Authors:  Ype de Jong; Esmee M van der Willik; Jet Milders; Yvette Meuleman; Rachael L Morton; Friedo W Dekker; Merel van Diepen
Journal:  BMC Nephrol       Date:  2021-09-13       Impact factor: 2.388

5.  Development of Digitally Obtainable 10-Year Risk Scores for Depression and Anxiety in the General Population.

Authors:  Davide Morelli; Nikola Dolezalova; Sonia Ponzo; Michele Colombo; David Plans
Journal:  Front Psychiatry       Date:  2021-08-13       Impact factor: 4.157

6.  Machine Learning on Early Diagnosis of Depression.

Authors:  Kwang-Sig Lee; Byung-Joo Ham
Journal:  Psychiatry Investig       Date:  2022-08-24       Impact factor: 3.202

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.